COVID-19 public health emergency ends, but research, lessons go on
Researchers from the University of Michigan School of Public Health discuss the end of the COVID-19 Public Health Emergency.
COVID-19
Wastewater dashboard adds monkeypox, flu and more for five southeast Michigan communities
A public dashboard that tracks pathogens detected in wastewater just added monitoring for monkeypox, influenza-A, norovirus GII and respiratory syncytial virus (RSV). Michigan Public Health researchers Marisa Eisenberg and Betsy Foxman are part of the project.
Researchers discover enzyme inhibitors to stop replication of SARS-CoV-2, forging a path for potential new antiviral drugs
Q&A with Rudy Richardson
Researchers from the University of Michigan School of Public Health studied two viral enzymes, Mpro and PLpro, essential for the survival of SARS-CoV-2, as targets for potential new antiviral drugs to defend against COVID-19. Their work was recently published in Computers in Biology and Medicine.
Lingering symptoms common after COVID hospitalization
New research from Andrew J. Admon
Many adults experience problems like coughing, chest pain, and fatigue 6 months after their stay.
Why Are Lots of Kids Likely to Be Sick This Holiday Season?
Aubree Gordon co-authors op-ed in the New York Times
In this New York Times opinion article, Aubree Gordon, associate professor of Epidemiology, discusses the respiratory viruses we'll likely see this winter.
What to know about the new COVID-19 booster shots
Aubree Gordon quoted in the New York Times
A new COVID-19 booster shot for the Omricon variant will be made available. Aubree Gordon, associate professor of Epidemiology at the University of Michigan School of Public Health, describes the number of weeks it takes for anti-bodies from the booster shot to start working.